Prepare for Lift-off – Botanix raises $40 million and strengthens leadership team
Botanix Pharmaceuticals Limited (ASX:BOT)—a clinical stage cannabinoid company—has received firm commitments for a $40 million placement led by specialist US-based biotech investment funds and leading US institutional investors. The $40 million in funding—which was offered at a price of $0.21 per fully paid ordinary share—will be used to support the company’s cannabinoid clinical development and […]